Cardiovascular magnetic resonance: Myocardial perfusion

Herz

Volumn 25, Issue 4, 2000, Pages 409-416

  Nagel, Eike ^a   Al Saadi, Nidal ^b   Fleck, Eckart ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b NONE

Author keywords

Ischemic heart disease; Magnetic resonance imaging; Myocardial perfusion

Indexed keywords

GADOLINIUM PENTETATE;

ACUTE HEART INFARCTION; ARTICLE; COMPUTER PROGRAM; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HUMAN; IMAGE ENHANCEMENT; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE DIAGNOSIS;

CONTRAST MEDIA; CORONARY CIRCULATION; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 0033924655     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000590050033     Document Type: Article

References (90)

1. Al-Saadi N, Nagel E, Gross M, et al. Improvement of myocardial perfusion reserve early after PTCA: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol (submitted).
2. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:379-83.
3. Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 1990;174:757-62.
4. Baer FM, Voth E, Theissen P, et al. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. Eur Heart J 1994;15:218-25.
5. Bauer W, Nadler W, Bock M, et al. Theory of the BOLD effect in the capillary region: an analytical approach for the determination of T*2 in the capillary network of myocardium. Magn Reson Med 1999;41:51-62.
6. Beache G, Kulke S, Kantor H, et al. Imaging perfusion deficits in ischemic heart disease with susceptibility-enhanced T2 weighted MRI. Preliminary human studies. Magn Reson Imaging 1998;16: 19-27.
7. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991;20:299-305.
8. Canby RC, Reeves RC, Evanochko WT, et al. Proton nuclear magnetic resonance relaxation times in severe myocardial ischemia. J Am Coll Cardiol 1987;10:412-20.
9. Canet E, Douek P, Janier M, et al. Influence of bolus volume and dose of gadolinium chelate for first-pass myocardial perfusion MR imaging studies. J Magn Reson Imaging 1995;5:411-5.
10. Cullen J, Horshfield M, Reek C, et al. A myocardial perfusion reserve index in humans using first-pass contrast enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33:1386-94.
11. de Roos A, van der Wall EE, Bruschke AV, et al. Magnetic resonance imaging in the diagnosis and evaluation of myocardial infarction. Magn Reson Q 1991;7:191-207.
12. de Roos A, van Rossum AC, van der Wall E, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989;172:717-20.
13. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825-35.
14. Dendale P, Franken PR, Holman E, et al. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 1998;82:375-7.
15. Diesbourg L, Prato F, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volume using a bolus injection of GD-DPTA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23:239-53.
16. Ding S, Wolff SD, Epstein FH. Improved coverage in dynamic contrast-enhanced cardiac MRI using interleaved gradient-echo EPI. Magn Reson Med 1998;39:514-9.
17. Duke MC, Duerinckx AJ, Hartiala J, et al. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction. AJR 1993;160: 963-70.
18. Eichenberger AC, Schuiki E, Kochli VD, et al. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging 1994;4:425-31.
19. Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of GD-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-31.
20. Fritz-Hansen T, Rostrup E, Ring P, et al. Quantification of gadolinium-DPTA concentrations for different inversion times using an IR-turbo flash pulse. A study on optimizing multislice perfusion imgaging. Magn Reson Imaging 1998;16:893-9.
21. Gallagher KP, Osakada G, Matsuzaki M, et al. Myocardial blood flow and function with critical coronary stenosis in exercising dogs. Am J Physiol 1982;243:H698-707.
22. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease [see comments]. J Nucl Med 1990;31: 1899-905.
23. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15: 459-74.
24. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.
25. Harris PA, Lorenz CH, Holburn GE, et al. Regional measurement of the GD-DTPA tissue partition coefficient in canine myocardium. Magn Reson Med 1997;38:541-5.
26. Hartnell G, Cerel A, Kamalesh M, et al. Detection of myocardial ischemia: value of combined myocardial perfusion and cineangiographic MR imaging. Am J Roentgenol 1994;163:1061-7.
27. Hauser AM, Gangadharan V, Ramos RG, et al. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985;5: 193-7.
28. Higgins CB, Lanzer P, Stark D, et al. Imaging by nuclear magnetic resonance in patients with chronic ischemic heart disease. Circulation 1984;69:523-31.
29. Higgins CB, Saeed M, Wendland M, et al. Contrast media for cardiothoracic MR imaging. J Magn Reson Imaging 1993;3:265-76.
30. Higgins CB, Saeed M, Wendland M. Contrast enhancement for the myocardium. Magn Reson Med 1991;22:347-53.
31. Jerosch Herold M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Card Imaging 1997;13:205-18.
32. Judd RM, Atalay MK, Rottman GA, et al. Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents. Magn Reson Med 1995;33:215-23.
33. Kashanian FK, Goldstein HA, Blumetti RF, et al. Rapid bolus injection of gadopentetate dimegiumine: absence of side effects in normal volunteers. AJNR 1990;1l:853-6.
34. Keijer JT, van Rossum AC, van Eenige MJ, et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 1995;130: 893-901.
35. Kety SS. Measurement of local contribution within the brain by means of inert, diffusible tracers; examination of the theory, assumptions and possible sources of error. Acta Neurol Scand 1965;14:Suppl:20-3.
36. Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94:3318-26.
37. Klein MA, Collier BD, Heilman RS et al. Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo fast low angle shot MR images. Am J Roentgenol 1993;161:257-63.
38. Larsson HB, Fritz-Hansen T, Rostrup E, et al. Myocardial perfusion modeling using MRI. Magn Reson Med 1996;35:716-26.
39. Larsson HB, Stubgaard M, Sondergaard L, et al. In vivo quantification of the unidirectional influx constant for GD-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-40.
40. Lauerma K, Virtanen KS, Sipila LM, et al. Multislice MRI in assessment of myocardial perfusion in patients with single vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96:2859-67.
41. Lauterbur PC. Image formation by induced local interactions. Examples employing nuclear magnetic resonance. Clin Orthop 1989;244:3-6.
42. Li D, Dhawale P, Rubin P, Haacke E, et al. Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using double-echo gradient-echo sequence. Magn Reson Med 1996;36:16-20.
43. Manning WJ, Atkinson DJ, Grossman W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991;18:959-65.
44. Manning WJ, Atkinson DJ, Parker JA, Assessment of intracardiac shunts with gadolinium-enhanced ultrafast MR imaging. Radiology 1992;184:357-61.
45. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole Sesta MIBI SPECT for detection of perfusion abnormalities in patients with one vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 1996;35:221-8.
46. Miller DD, Holmvang G, Gill JB, et al. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia.-Magn Reson Med 1989;10:246-55.
47. Mühler A, Saeed M, Brasch RC, et al. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats. Radiology 1992;183:523-8.
48. Mühler A. Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments. Magma 1995;3:21-3.
49. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31: 534-40.
50. Nagel E, Al-Saadi N, Paetsch I, et al. Magnetic resonance myocardial perfusion reserve for the detection of coronary artery disease in an unselected patient population. Presented on the 72nd Annual Meeting of the American Heart Assossiation, Atlanta 1999.
51. Nagel E, Lehmkuhl HB, Bocksch W, et al. High dose dobutamine magnetic resonance imaging for the detection of myocardial ischemia. Circulation 1999;99:763-70.
52. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987;59:23C-30C.
53. Niemi P, Poncelet B, Kwong K, et al. Myocardial intensity changes associated with flow stimulation in blood oxygenation sensitive magnetic resonance imaging. Magn Reson Med 1996;36:78-82.
54. Niendorf HP, Haustein J, Louton T, et al. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial. Invest Radiol 1991;26 Suppl 1:S221-3.
55. Nishimura T, Kobayashi H, Ohara Y, et al. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. AJR 1989;153:715-20.
56. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992;70:34-40.
57. Pipe JG, Ahunbay E, Menon P. Effects of interleaf order for spiral MRI of dynamic processes. Magn Reson Med 1999;41:417-22.
58. Ramani K, Judd RM, Holly TA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998;98:4687-94.
59. Reeder SB, Atalar E, Faranesh AZ, et al. Multi-echo segmented k-space an optimized hybrid sequence for ultrafast cardiac imaging. Magn Reson Med 1999;41:375-85.
60. Rehr RB, Peshock RM, Malloy CR, et al. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986;57:864-8.
61. Rogers W, Kramer C, Geskin G, et al. Early contrast enhanced MRI predicts late functional recovery after reperfused mycoardial infarction. Circulation 1999;99:744-50.
62. Saeed M, Wagner S, Wendland MF, et al. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enhanced MR imaging. Radiology 1989;172:59-64.
63. Saeed M, Wendland M, Masui T, et al. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-9.
64. Saeed M, Wendland MF, Takehara Y, et al. Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium. Radiology 1992;182:675-83.
65. Saeed M, Wendland MF, Yu KK, et al. Dual effects of gadodiamide injection in depiction of the region of myocardial ischemia. J Magn Reson Imaging 1993;3:21-9.
66. Schaefer S, Lange RA, Gutekunst DP, et al. Contrast enhanced magnetic resonance imaging of hypoperfused myocardium. Invest Radiol 1991;26:551-6.
67. Schaefer S, van Tyen R, Saioner D. Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress. Radiology 1992;185:795-801.
68. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 1994;35:693-8.
69. Schwitter J, Debatin F. MRI contrast in the assessment of myocardial perfusion. Advanc MRI Contrast 1995;334-47.
70. Schwitter J, Debatin JF, von Schulthess GK, et al. Normal myocardial perfusion assessed with multishot echo-planar imaging. Magn Reson Med 1997;37:140-7.
71. Simone GL, Mullani NA, Page DA, et al. Utilization statistics and diagnostic accuracy of a nonhospital-based positron emission tomography center for the detection of coronary artery disease using rubidium-82. Am J Physiol Imaging 1992;7:203-9.
72. Thompson RC, Liu P, Brady TJ, et al. Serial magnetic resonance imaging in patients following acute myocardial infarction. Magn Reson Imaging 1991;9:155-8.
73. Tofts PS. Modeling tracer kinetics in dynamic GD-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
74. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd DTPA in normal and diseased canine myocardium. Magn Reson Med 1993; 30:337-46.
75. Tong CY, Prato FS, Wisenberg G, et al. Techniques for the measure-ment of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Magn Reson Med 1993;30:332-6.
76. Tscholakoff D, Higgins C, Sechtem U, et al. Occlusive and reperfused myocardial infarcts: effect of GD-DPTA on ECG-gated MR imaging. Radiology 1986;160:515-9.
77. Vallee JP, Sostman HD, MacFall JR, et al. MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study. Magn Reson Med 1997;38:981-9.
78. van Rossum AC, Visser FC, van Eenige MJ, et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990;65:845-51.
79. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994;90:127-38.
80. Wacker CM, Bock M, Hartlep AW, et al. BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. Magma 1999;8:48-54.
81. Wacker CM, Bock M, Hartlep AW, et al. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and TI measurements. Magn Reson Med 1999;41:686-95.
82. Walsh EG, Doyle M, Lawson MA, et al. Multislice first-pass myocardial perfusion imaging on a conventional clinical scanner. Magn Reson Med 1995;34:39-47.
83. Wendland MF, Saeed M, Yu KK, et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 1994;32:319-29.
84. Wilke N Jerosch-Herold M, Wand Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-84.
85. Wilke N, Jerosch-Herold M, Stillman AE, et al. Concepts of myocardial perfusion imaging in magnetic resonance imaging. Magn Reson Q 1994;10:249-86.
86. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-97.
87. Williams BR, Mullani NA, Jansen DE, et al. A retrospective study of the diagnostic accuracy of a community hospital-based PET center for the detection of coronary artery disease using rubidium-82. J Nucl Med 1994;35:1586-92.
88. Wolff S, Day R, Santiago L, et al. Assessment of first-pass myocardial perfusion imaging during rest and adenosine stress: comparison with cardiac catheterization. Proc Int Soc Magn Reson Med 1999;7:305.
89. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97: 765-72.
90. Yu KK, Saeed M, Wendland MF, et al. Real-time dynamics of an extravascular magnetic resonance contrast medium in acutely infarcted myocardium using inversion recovery and gradient-recalled echo-planar imaging. Invest Radiol 1992;27;927-34.